King Wealth Management »

Aldeyra Therapeutics shares owned by King Wealth Management

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by King Wealth Management from 13F filings

Historical chart of King Wealth Management investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by King Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by King Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $33k 10k 3.30

More positions owned by King Wealth Management

Ishares Tr Ivv Etf (IVV)
Invesco Qqq Tr Etf (QQQ)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Spy Etf (SPY)
Ishares Tr Ijh Etf (IJH)
Apple (AAPL)
Eli Lilly & Co. (LLY)
Visa (V)
NVIDIA Corporation (NVDA)
Ishares Tr Ijr Etf (IJR)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
McDonald's Corporation (MCD)
Ishares Tr Itot Etf (ITOT)
Fidelity Covington Tr Ftec Etf (FTEC)

View all positions for King Wealth Management

Top funds holding Aldeyra Therapeutics

Perceptive Advisors
Knoll Capital Management
Vanguard Group
BlackRock
Kennedy Capital Management
Geode Capital Management
Damian Sousa
Verition Fund Management
Dimensional Fund Advisors
D. E. Shaw & Co
Acadian Asset Management
Bank of America Corporation
Northern Trust
Millennium Management
Wells Fargo & Company

View all funds holding Aldeyra Therapeutics